354 Lenvatinib and pembrolizumab in advanced endometrial carcinoma (EC): long-term efficacy and safety update from a phase 1b/2 study
oleh: Emmett Schmidt, Matthew Taylor, Allen Cohn, Corina Dutcus, Marcia Brose, Robert Orlowski, Jie Huang, Carol Aghajanian, Margarita Romeo, Raquel Bratos, Mark Messing, Lea Dutta
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.